10.1186/s13041-021-00776-9 - Pharmacological inhibition of nSMase2...

This document has been corrected

Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model

10.1186/s13041-021-00776-9

Published Online: 2021-04-19

Journal: Molecular Brain•Publisher: Springer Science and Business Media LLC

Authors: Asa Hatami•Chris Jean Elias•Chunni Zhu•Jesus Campagna•Karen Hoppens Gylys•Michael Jun•Mikhail Melnik•Patricia Spilman•Samantha Focht•Sujyoti Chandra•Tina Bilousova•Varghese John•Whitaker Cohn

This document has been corrected

Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model

10.1186/s13041-021-00776-9

Published Online: 2021-04-19

Journal: Molecular Brain

NOW

2021-07-08•Correction

Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model

10.1186/s13041-021-00816-4

* information provided by CrossRef

2021-07-08•Correction

10.1186/s13041-021-00816-4

* information provided by CrossRef

2021-04-19•Published

2021-07-08•Correction

Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model

10.1186/s13041-021-00816-4

* information provided by CrossRef

This document has been corrected

Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model

10.1186/s13041-021-00776-9

Published Online: 2021-04-19

Journal: Molecular Brain•Publisher: Springer Science and Business Media LLC